News chronological

Showing 10 items before 1051762

AXIOS (Avery Lotz) - Colbert defies CBS over interview with Texas Senate candidate James Talarico

Late-night host Stephen Colbert said Monday evening that CBS barred him from airing an interview with James Talarico, a Texas Democrat running for Senate, citing a recent federal directive . Why it matters: CBS has faced mounting scrutiny in recent months that its news arm and parent company, Paramount Skydance, are succumbing to pressure from President Trump's administration. Driving the news: Colbert said on air that CBS' lawyers told his show that it could not have Talarico, a Texas state representative, on the broadcast. - "Then I was told, in some uncertain terms, that not only could I not have him on, I could not mention me not having him on," he said. "And because my network clearly doesn't want us to talk about this, let's talk…

Late-night host Stephen Colbert said Monday evening that CBS barred him from airing an interview with James Talarico, a Texas Democrat running for Senate, citing a recent federal directive . Why it matters: CBS has faced mounting scrutiny in recent months that its news arm and parent company, Paramount Skydance, are succumbing to pressure from President Trump's administration. Driving the news: Colbert said on air that CBS' lawyers told his show that it could not have Talarico, a Texas state representative, on the broadcast. - "Then I was told, in some uncertain terms, that not only could I not have him on, I could not mention me not having him on," he said. "And because my network clearly doesn't want us to talk about this, let's talk…Open

AXIOS (Nathan Bomey) - Bayer reaches $7.25B settlement over Monsanto's Roundup accusations

Bayer has agreed to a $7.25 billion deal to settle tens of thousands of lawsuits that its weedkiller Roundup caused cancer. The big picture: Bayer — which acquired Roundup when it bought Monsanto in 2018 — announced Tuesday that it'll compensate people who allegedly suffered non-Hodgkin lymphoma due to exposure to Roundup. - The German drug giant and crop science company had originally reached a $10 billion settlement in 2020 that covered short-term claims up to four years — but that deal was later scuttled amid legal scrutiny over the claims process. - The new compensation deal covers claims for up to 21 years. - The company didn't disclose the average amount expected to be distributed to each recipient. Zoom out: The latest…

Bayer has agreed to a $7.25 billion deal to settle tens of thousands of lawsuits that its weedkiller Roundup caused cancer. The big picture: Bayer — which acquired Roundup when it bought Monsanto in 2018 — announced Tuesday that it'll compensate people who allegedly suffered non-Hodgkin lymphoma due to exposure to Roundup. - The German drug giant and crop science company had originally reached a $10 billion settlement in 2020 that covered short-term claims up to four years — but that deal was later scuttled amid legal scrutiny over the claims process. - The new compensation deal covers claims for up to 21 years. - The company didn't disclose the average amount expected to be distributed to each recipient. Zoom out: The latest…Open

AXIOS (Natalie Daher) - The long game: Winter Olympians redefining their prime

For most of us, 40 is the new 30. For elite athletes at this year's Winter Olympics , 40 is something else entirely: rare air. Why it matter: The Games aren't just a showcase of peak performance anymore. They're a test of longevity. How long can greatness last? - From the first-ever mother-son duo to compete in the Olympics to athletes who've come out of retirement to medal in Milan, this year's field is redefining what an Olympic career can look like. They still get retirement questions. - They're asked often to explain how they stay in the game. - But they also bring something younger competitors can't: perspective — a long view of the injuries, setbacks, reinventions and second acts that shape a professional athlete's life. For…

For most of us, 40 is the new 30. For elite athletes at this year's Winter Olympics , 40 is something else entirely: rare air. Why it matter: The Games aren't just a showcase of peak performance anymore. They're a test of longevity. How long can greatness last? - From the first-ever mother-son duo to compete in the Olympics to athletes who've come out of retirement to medal in Milan, this year's field is redefining what an Olympic career can look like. They still get retirement questions. - They're asked often to explain how they stay in the game. - But they also bring something younger competitors can't: perspective — a long view of the injuries, setbacks, reinventions and second acts that shape a professional athlete's life. For…Open